Funded Programs Conferences

Concurrent 2009 Keystone Symposia meetings entitled: Neurodegenerative Diseases: New Molecular Mechanisms and Axonal Connections: Molecular Cues for Development and Regeneration Investigator(s): Andrew Robertson, PhD Institution(s): Keystone Symposia on Molecular and Cellular Biology

Summary:
This Keystone symposium combines the meeting on Neurodegenerative Diseases with The meeting on Axonal Connections: Molecular Cues for Development and Regeneration. These concurrent meetings will bring together researchers in the fields of axon development, degeneration and regeneration and promote exchange of ideas, information and collaboration among these fields. These meetings will also train young scientists in the questions, approaches, and opportunities in these exciting and topical research areas and promote scientific and translational goals of understanding the basic mechanisms for the formation of neural circuits and for developing new therapeutic strategies for repair. Holding these meetings jointly, including a common keynote address and three shared plenary sessions plus considerable shared unstructured time, provides a unique opportunity for bridging an in-depth discussion of neurological disease pathogenesis with a high-level discourse on the molecular and physiological mechanisms governing the normal biology of axon growth and regeneration. The target audience for this symposium is researchers investigating mechanisms in neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), triple repeat diseases, amyotrophic lateral sclerosis (ALS), and researchers focused on molecular mechanisms for axon development and regeneration.

10th International Symposium on the Treatment of Alzheimer's Disease Investigator(s): Kenneth Rockwood, MD, FRCPC Institution(s): Geriatric Medicine Research Unit

Summary:
Dr. Kenneth Rockwood is applying for funding for the 10th International Symposium on the Treatment of Alzheimer\'s Disease. This interdisciplinary forum aims to facilitate discussion on existing models of disease treatment effects, phenomenological studies of treatment, and mathematical models of disease expression and its modification by pharmacotherapy. Several publications have resulted from previous symposia.